NAMS Stock Summary and Trading Ideas (Newamsterdam Pharma Company N.V. - | NASDAQ:NAMS)

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

What symbol and exchange does Newamsterdam Pharma Company N.V. - shares trade?

Newamsterdam Pharma Company N.V. - trades on the NASDAQ stock market under the symbol NAMS.

What is Newamsterdam Pharma Company N.V. - stock price doing today?

As of September 4, 2026, NAMS stock price declined to $25.40 with 525,827 million shares trading.

What is Newamsterdam Pharma Company N.V. -'s Beta?

NAMS has a beta of 0.75, meaning it tends to be less sensitive to market movements. NAMS has a correlation of 0.02 to the broad based SPY ETF.

How much is Newamsterdam Pharma Company N.V. - worth?

NAMS has a market cap of $3.04 billion. This is considered a Mid Cap stock.

How much money does Newamsterdam Pharma Company N.V. - make?

Last quarter Newamsterdam Pharma Company N.V. - reported $4 million in Revenue and -$.52 earnings per share. This beat revenue expectation by $1 million and missed earnings estimates by -$.09.

What is the highest and lowest price Newamsterdam Pharma Company N.V. - traded in the last 3 year period?

In the last 3 years, NAMS traded as high as $42.21 and as low as $5.63.

What are the top ETFs holding Newamsterdam Pharma Company N.V. -?

The top ETF exchange traded funds that NAMS belongs to (by Net Assets): CGMM, VHT, SBIO, ONEQ, FHLC.

Is Newamsterdam Pharma Company N.V. - (NAMS) a good investment?

NAMS has underperformed the market in the last year with a price return of -1.0% while the SPY ETF gained +19.8%. NAMS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -22.3% and -8.9%, respectively, while the SPY returned +2.0% and +0.6%, respectively.

What are the support and resistance levels for Newamsterdam Pharma Company N.V. - (NAMS)?

NAMS support price is $25.20 and resistance is $26.50 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NAMS shares will trade within this expected range on the day.